Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Celsion (CLSN)

Add to Watchlists
Create an Alert
3.44 +0.03  +0.88% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
CLSN Price Chart
View All Events

CLSN Events

Date Type Description
Mar 13 Earnings Celsion Corporation Q4 2013 Earning Result. Estimate: -0.25.
Mar 10 Misc Celsion Corporation Q4 2013 Earning Conference Call
Nov 12 Misc Celsion Corporation to Hold Third Quarter 2013 Financial Results Conference Call on Tuesday, November 12, 2013
Nov 12 Earnings Celsion Corporation Q3 2013 Release. Estimate: -0.05.
Oct 29 Splits Ratio: 4002799348806897:18014398509481984
Sep 14 Misc Celsion Announces Official Thermodox® Heat Study Results to Be Presented at the International Liver Cancer Association (Ilca) 2013 Annual Conference in Washington, d.c. On September 14, 2013
Aug 08 Misc Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
Aug 08 Earnings Celsion Corporation to Hold Second Quarter 2013 Financial Results. Estimate: -0.54.
Jul 19 Misc AGM Event for Celsion Corp
May 09 Misc Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013
View All Performance Charts

CLSN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Celsion is down 0.07% over the last year vs S&P 500 Total Return up 22.59%, ACADIA Pharmaceuticals up 53.08%, and Actelion up 71.93%.

Get Quote for

Portfolio Strategies Featuring CLSN

Did Celsion make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CLSN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CLSN 3.44 +0.03 +0.88% 59.20M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.